Physician profile
Ryan Andrews
NPI 1578929592
$7,105.43
in general payments reported to CMS, 2019-2025
8 companies · $2,597 in 2025
The $2,597 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $458 · 2021: $388 · 2022: $1,168 · 2023: $696 · 2024: $1,210 · 2025: $2,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104 · Consulting Fee: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,103.99 |
| Consulting Fee | $1,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,560.02 | 2019-2025 | Augment Injectable, Citrefix, Sonicpin |
| Acuitive Technologies, INC | $1,585.11 | 2025 | 7 X15mm Citrelock Implant, 6 X 23mm Citrelock Implant, 4.5 X 24mm Citrefix Implant |
| Depuy Synthes Sales INC. | $342.30 | 2019-2023 | Na, Fibergraft Aeridyan Matrix, Fibulink |
| Smith+Nephew, INC. | $304.67 | 2024-2025 | Stravix Mesh, Stravix Pl, Grafix Pl |
| Abbott Laboratories | $139.28 | 2025 | Esprit |
| Organogenesis INC. | $119.18 | 2022 | |
| Bioventus LLC | $36.66 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.